Cargando…
IL13 May Play an Important Role in Developing Eosinophilic Chronic Rhinosinusitis and Eosinophilic Otitis Media with Severe Asthma
A woman in her 50s was a super responder to benralizumab administered for the treatment of severe bronchial asthma (BA) with eosinophilic chronic rhinosinusitis with nasal polyp (ECRS) and eosinophilic otitis media (EOM). She exhibited the gradual exacerbation of ECRS/EOM despite good control of BA...
Autores principales: | Shimizu, Hideyasu, Hayashi, Masamichi, Kato, Hisayuki, Nakagawa, Mitsuru, Imaizumi, Kazuyoshi, Okazawa, Mitsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537786/ https://www.ncbi.nlm.nih.gov/pubmed/34681869 http://dx.doi.org/10.3390/ijms222011209 |
Ejemplares similares
-
Rapid and remarkable effectiveness of benralizumab for treating severe bronchial asthma with intractable eosinophilic rhinosinusitis and eosinophilic otitis media: A case report
por: Shimizu, Hideyasu, et al.
Publicado: (2020) -
COVID-19 symptom-onset to diagnosis and diagnosis to treatment intervals are significant predictors of disease progression and hospitalization in high-risk patients: A real world analysis
por: Shimizu, Hideyasu, et al.
Publicado: (2023) -
Improvement of Eosinophilic Otitis Media by Optimized Asthma Treatment
por: Tanaka, Yukako, et al.
Publicado: (2013) -
Optimal control of asthma improved eosinophilic otitis media
por: Seo, Yukako, et al.
Publicado: (2018) -
Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis
por: Numata, Takanori, et al.
Publicado: (2019)